Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011

Journal of Medical Virology

Volumn 85, Issue 3, 2013, Pages 379-387

  Yang, Ji Rong ^a   Huang, Yuan Pin ^a   Chang, Feng Yee ^a   Hsu, Li Ching ^a   Huang, Hsiang Yi ^a   Pan, Yi Tsan ^a   Lin, Yu Cheng ^a   Wu, Ho Sheng ^a,b   Liu, Ming Tsan ^a  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

A(H1N1)pdm09; Influenza A viruses; Neuraminidase; Oseltamivir resistance

Indexed keywords

OSELTAMIVIR; VIRUS SIALIDASE;

AMINO ACID SUBSTITUTION; ARTICLE; CLADISTICS; ENZYME ACTIVITY; ENZYME INHIBITION; EPIDEMIC; FREQUENCY ANALYSIS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IC 50; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; TAIWAN; VIRAL GENETICS; VIRUS CHARACTERIZATION; VIRUS DETECTION;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEURAMINIDASE; OSELTAMIVIR; RNA, VIRAL; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; TAIWAN; VIRAL PROTEINS;

EID: 84873154021     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23482     Document Type: Article

References (41)

1. Bandaranayake D, Jacobs M, Baker M, Hunt D, Wood T, Bissielo A, Macfarlane M, Lopez L, Mackereth G, Huang Q. 2011. The second wave of 2009 pandemic influenza A(H1N1) in New Zealand, January-October 2010. Euro Surveill 16: pii19788.
2. Barr IG, Cui L, Komadina N, Lee RT, Lin RT, Deng Y, Caldwell N, Shaw R, Maurer-Stroh S. 2010. A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand, and Singapore. Euro Surveill 15: pii19692.
3. Baz M, Abed Y, Simon P, Hamelin ME, Boivin G. 2010. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis 201: 740- 745.
4. Bloom JD, Gong LI, Baltimore D. 2010. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328: 1272- 1275.
5. Bloom JD, Nayak JS, Baltimore D. 2011. A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase. PLoS ONE 6: e22201.
6. CDC. 2009a. Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 58: 467- 470.
7. CDC. 2009b. Update: Drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 58: 433- 435.
8. CDC. 2010. Update: Influenza activity-United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 in fluenza vaccine. MMWR Morb Mortal Wkly Rep 59: 423- 430.
9. Duan S, Boltz DA, Seiler P, Li J, Bragstad K, Nielsen LP, Webby RJ, Webster RG, Govorkova EA. 2010. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog 6: e1001022.
10. Ellis J, Galiano M, Pebody R, Lackenby A, Thompson C, Bermingham A, McLean E, Zhao H, Bolotin S, Dar O, Watson JM, Zambon M. 2011. Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill 16: pii19760.
11. Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, Kaneda S, Kawaoka Y. 2012. Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses. J Virol 86: 121- 127.
12. Hamelin ME, Baz M, Abed Y, Couture C, Joubert P, Beaulieu E, Bellerose N, Plante M, Mallett C, Schumer G, Kobinger GP, Boivin G. 2010. Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog 6: e1001015.
13. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. 2009. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 15: 155- 162.
14. Holmes EC. 2010. Virology. Helping the resistance. Science 328: 1243- 1244.
15. Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D'Souza H, Komadina N, Shaw R, Kelso A, Barr IG. 2009. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia, and South Africa. Antiviral Res 83: 90- 93.
16. Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Gehrig N, Kelso A. 2011. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med 365: 2541- 2542.
17. Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA. 2002. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res 55: 307- 317.
18. Kiso M, Shinya K, Shimojima M, Takano R, Takahashi K, Katsura H, Kakugawa S, Le MT, Yamashita M, Furuta Y, Ozawa M, Kawaoka Y. 2010. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog 6: e1001079.
19. Le QM, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, Horby P. 2010. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med 362: 86- 87.
20. Mak G, Leung C, Cheng K, Wong K, Lim W. 2011. Evolution of the haemagglutinin gene of the influenza A(H1N1)2009 virus isolated in Hong Kong, 2009-2011. Euro Surveill 16: pii19807.
21. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M. 2009. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis 15: 552- 560.
22. Moore C, Galiano M, Lackenby A, Abdelrahman T, Barnes R, Evans MR, Fegan C, Froude S, Hastings M, Knapper S, Litt E, Price N, Salmon R, Temple M, Davies E. 2011. Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit. J Infect Dis 203: 18- 24.
23. Moscona A. 2009. Global transmission of oseltamivir-resistant influenza. N Engl J Med 360: 953- 956.
24. Mytton OT, Rutter PD, Mak M, Stanton EA, Sachedina N, Donaldson LJ. 2012. Mortality due to pandemic (H1N1) 2009 influenza in England: A comparison of the first and second waves. Epidemiol Infect 140: 1533- 1541.
25. Nelson M, Spiro D, Wentworth D, Beck E, Fan J, Ghedin E, Halpin R, Bera J, Hine E, Proudfoot K, Stockwell T, Lin X, Griesemer S, Kumar S, Bose M, Viboud C, Holmes E, Henrickson K. 2009. The early diversification of influenza A/H1N1pdm. PLoS Curr 1: RRN1126.
26. Reece PA. 2007. Neuraminidase inhibitor resistance in influenza viruses. J Med Virol 79: 1577- 1586.
27. Regoes RR, Bonhoeffer S. 2006. Emergence of drug-resistant influenza virus: Population dynamical considerations. Science 312: 389- 391.
28. Seibert CW, Kaminski M, Philipp J, Rubbenstroth D, Albrecht RA, Schwalm F, Stertz S, Medina RA, Kochs G, Garcia-Sastre A, Staeheli P, Palese P. 2010. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol 84: 11219- 11226.
29. Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, Smit M, Macken C, Hata M, Gog J, Miller MA, Holmes EC. 2007. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 24: 1811- 1820.
30. Storms A, Gubareva L, Su S, Wheeling J, Okomo-Adhiambo M, Pan C-Y. 2012. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis 18: 308- 311.
31. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596- 1599.
32. Ward P, Small I, Smith J, Suter P, Dutkowski R. 2005. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 55: i5- i21.
33. Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, Mills RG, Ward P. 2001. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 20: 127- 133.
34. WHO. 2009. Sequencing primers and protocol. Available from http://www.who.int/csr/resources/publications/swineflu/GenomePrimers_20090512.pdf.
35. WHO. 2010. Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010. Wkly Epidemiol Rec 85: 37- 40.
36. WHO. 2011a. Summary of influenza antiviral susceptibility surveillance findings, September 2010-March 2011 available from: http://www.who.int/influenza/gisrs_laboratory/updates/antiviral_susceptibility/en/index.html, accessed on December 4, 2011
37. WHO. 2011b. Update on oseltamivir resistance in influenza A(H1N1)2009 viruses available from: http://www.who.int/influenza/surveillance_monitoring/updates/2011_08_26_weekly_web_update_oseltamivir_resistance.pdf accessed on December 4, 2011.
38. Yang JR, Huang YP, Lin YC, Su CH, Kuo CY, Hsu LC, Wu HS, Liu MT. 2010. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza a viruses in Taiwan. Antiviral Res 88: 256- 262.
39. Yang JR, Huang YP, Chang FY, Hsu LC, Lin YC, Su CH, Chen PJ, Wu HS, Liu MT. 2011a. New variants and age shift to high fatality groups contribute to severe successive waves in the 2009 influenza pandemic in Taiwan. PLoS ONE 6: e28288.
40. Yang JR, Lin YC, Huang YP, Su CH, Lo J, Ho YL, Yao CY, Hsu LC, Wu HS, Liu MT. 2011b. Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2009. PLoS ONE 6: e18177.
41. Yang JR, Lo J, Liu JL, Lin CH, Ho YL, Chen CJ, Wu HS, Liu MT. 2009. Rapid SYBR green I and modified probe real-time reverse transcription-PCR assays identify influenza H1N1 viruses and distinguish between pandemic and seasonal strains. J Clin Microbiol 47: 3714- 3716.